CN1829528A - 包含胃泌素化合物的组合物及其在糖尿病中的应用 - Google Patents

包含胃泌素化合物的组合物及其在糖尿病中的应用 Download PDF

Info

Publication number
CN1829528A
CN1829528A CNA200480022042XA CN200480022042A CN1829528A CN 1829528 A CN1829528 A CN 1829528A CN A200480022042X A CNA200480022042X A CN A200480022042XA CN 200480022042 A CN200480022042 A CN 200480022042A CN 1829528 A CN1829528 A CN 1829528A
Authority
CN
China
Prior art keywords
weeks
compositions
treatment
gastrin
beneficial effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200480022042XA
Other languages
English (en)
Chinese (zh)
Inventor
A·克鲁兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Waratah Pharmaceuticals Inc
Skyepharma Canada Inc
Original Assignee
RTP Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by RTP Pharma Inc filed Critical RTP Pharma Inc
Publication of CN1829528A publication Critical patent/CN1829528A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CNA200480022042XA 2003-05-27 2004-05-27 包含胃泌素化合物的组合物及其在糖尿病中的应用 Pending CN1829528A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US03/16660 2003-05-27
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes

Publications (1)

Publication Number Publication Date
CN1829528A true CN1829528A (zh) 2006-09-06

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200480022042XA Pending CN1829528A (zh) 2003-05-27 2004-05-27 包含胃泌素化合物的组合物及其在糖尿病中的应用

Country Status (11)

Country Link
EP (1) EP1648495A2 (de)
JP (1) JP2007513059A (de)
CN (1) CN1829528A (de)
AU (1) AU2004243541A1 (de)
BR (1) BRPI0410710A (de)
CA (1) CA2527186A1 (de)
MX (1) MXPA05012605A (de)
NO (1) NO20055582L (de)
PL (1) PL379145A1 (de)
RU (1) RU2005140518A (de)
WO (1) WO2004105780A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2315350T3 (es) 2001-01-12 2009-04-01 Waratah Pharmaceuticals Inc. Composiciones para la introduccion de la neogenesis de islotes, que contienen unos ligandos para el receptor de gastrina/cck y ligandos para el receptor de efg.
EP1837031B1 (de) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Methoden und Kompositionen um Diabetes zu behandeln
JP2005533775A (ja) 2002-06-07 2005-11-10 ワラタ ファーマシューティカルズ， インコーポレイテッド 糖尿病を処置するための組成物および方法
CA2554458A1 (en) * 2004-01-30 2005-08-11 Waratah Pharmaceuticals, Inc. The combined use of glp-1 agonists and gastrin for regulating blood glucose levels
WO2008106779A1 (en) * 2007-03-02 2008-09-12 Waratah Pharmaceuticals Inc. Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
WO1995019785A1 (en) * 1994-01-24 1995-07-27 Research Triangle Pharmaceuticals Ltd. Treatment for juvenile diabetes
ES2315350T3 (es) * 2001-01-12 2009-04-01 Waratah Pharmaceuticals Inc. Composiciones para la introduccion de la neogenesis de islotes, que contienen unos ligandos para el receptor de gastrina/cck y ligandos para el receptor de efg.
AU2003283004A1 (en) * 2002-10-22 2004-05-13 Waratah Pharmaceuticals, Inc. Treatment of diabetes

Also Published As

Publication number Publication date
RU2005140518A (ru) 2007-07-10
NO20055582D0 (no) 2005-11-25
WO2004105780A3 (en) 2005-01-20
CA2527186A1 (en) 2004-12-09
WO2004105780A2 (en) 2004-12-09
EP1648495A2 (de) 2006-04-26
PL379145A1 (pl) 2006-07-24
MXPA05012605A (es) 2006-02-22
JP2007513059A (ja) 2007-05-24
NO20055582L (no) 2006-02-27
AU2004243541A1 (en) 2004-12-09
BRPI0410710A (pt) 2006-06-13

Similar Documents

Publication Publication Date Title
CN1268391C (zh) 外周给予的glp－1类似物和衍生物在控制肥胖中的用途
CN1243770C (zh) 神经营养生长因子
CN1501809A (zh) 应用胰高血糖素样促胰岛肽的长期治疗方案
CN1283997A (zh) 角质形成细胞生长因子－2制剂
CN1703424A (zh) Glp－1衍生物及其经粘膜吸收的制剂
CN1468258A (zh) 胰高血糖素样肽-1类似物
CN1622822A (zh) 含有生长素释放肽的药物组合物
CN1229357A (zh) 用生长抑素兴奋剂抑制纤维变性的方法
CN1589279A (zh) 有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽
US20090117102A1 (en) Methods and compositions using CD3 agonists
CN101035806A (zh) 新的糊精家族多肽－6（afp－6）类似物和制备和使用它们的方法
CN1582301A (zh) 有效治疗肿瘤和其它需要除去或破坏细胞的疾病的肽
CN1150030C (zh) 重组人甲胎蛋白及其用途
CN1264307A (zh) 改善上胃肠道功能的方法
CN1829528A (zh) 包含胃泌素化合物的组合物及其在糖尿病中的应用
CN1917898A (zh) 用于治疗非典型肺部感染的血管活性肠肽的生物活性物质
CN1799624A (zh) 一类封闭人类HIF－1α基因和调控网络中下游相关基因的染色质肽
CN1190437A (zh) 骨刺激因子
CN1802170A (zh) 利用IFN－β治疗慢性炎性脱髓鞘性多神经病
CN1257187C (zh) 钙网蛋白－肿瘤坏死因子相关凋亡诱导配体的融合蛋白及其制法和用途
CN1893970A (zh) β－淀粉样蛋白－类似物－T－细胞表位疫苗
CN1056537C (zh) 一种药物制剂
CN1875104A (zh) 来自内皮抑素n－末端的抗血管生成肽
CN1244375C (zh) 人肝再生相关蛋白及其应用
CN1372474A (zh) 用于预防或减轻病理性血管发生状况的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication